PAREXEL Informatics President Named a 2016 Computerworld Premier 100 Technology Leader
BOSTON, December 15, 2015 — PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, announced that IDG’s Computerworld named Xavier Flinois, President, PAREXEL Informatics, a 2016 Premier 100 Technology Leaders honoree. The Premier 100 spotlights 100 leaders in technology and business for their exceptional technology leadership and innovative approaches to business challenges.
At PAREXEL, Flinois leads a global team of more than 2,500 technology professionals, including corporate IT and PAREXEL Informatics. Under his leadership, PAREXEL continues to strengthen its leadership position as a technology services provider for the life sciences industry. By embracing “SMAC” (social media, mobile, analytics, and cloud) technologies, PAREXEL Informatics develops solutions that optimize clinical research management processes for clients.
“This award honors PAREXEL’s long history of innovation in clinical trial technologies and the dedicated PAREXEL Informatics team,” said Flinois. “At PAREXEL, our mission is to bring science to the real world by simplifying a client’s journey at every step. Ultimately, our goal is to give our clients the tools to make technology-enabled and data-driven business decisions, helping to reduce risk, increase clinical trial efficiency, and speed time to market for our clients and for patients.”
“The Premier 100 awards program showcases the strategic thinking of an elite group of IT leaders who are using technology to digitally transform their organizations,” said Scot Finnie, Editor-in-Chief, Computerworld. “These 100 men and women are working hand-in-hand with their business colleagues to give their organizations a competitive edge while giving their employees a place to grow their careers. We’re pleased to recognize their leadership and honor their achievements.”
Computerworld is the leading IT media brand helping senior IT, business decision-makers and key influencers navigate change with effective business strategy. As the voice of business technology, Computerworld enables the IT value chain with unique editorial coverage from setting strategies to deriving value. Computerworld’s award-winning website (www.computerworld.com), focused conference series, strategic marketing solutions and research forms the hub of the world’s largest (40+ edition) global IT media network and provides opportunities for IT vendors to engage this audience. Computerworld leads the industry with an online audience of over 7.5 million monthly page views (Omniture, November 2014 – January 2015 average) and was recognized in BtoB’s 2013 Media Power 50 list; recognition Computerworld has received for more than 5 consecutive years. Computerworld is published by IDG Enterprise, a subsidiary of International Data Group (IDG), the world’s leading media, events and research company. Company information is available at www.idgenterprise.com.
About the Premier 100 Technology Leadership Awards
The Premier 100 program was created in 2000 to spotlight individuals who have had a positive impact on their organizations through technology. These are individuals who manage internal IT organizations, mentor and motivate their IT teams and business colleagues, create a positive work environment, envision innovative solutions to business challenges and effectively manage and execute IT strategies. Each year nominees are invited to complete a survey that addresses a number of topics, including their background and experience and their attitude toward risk and innovation. Using Computerworld’s IT Leader Index, which is a measurement of how closely an individual matches our definition of the IT Leader, we analyze the data. Each year, 100 honorees are selected to receive this life-time recognition award. Information on previous honorees can be viewed at: http://www.computerworld.com/s/article/9065479/Premier_100_IT_Leaders.
About PAREXEL International
PAREXEL International Corporation is a leading global biopharmaceutical services organization, providing a broad range of expertise-based contract research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. PAREXEL Informatics provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL has offices in 80 locations in 51 countries around the world, and had approximately 18,620 employees in the first quarter. For more information about PAREXEL International visit www.PAREXEL.com.
PAREXEL and PAREXEL Informatics are trademarks or registered trademarks of PAREXEL International Corporation or its affiliates.
This release contains “forward-looking” statements regarding future results and events. For this purpose, any statements contained herein that are not statements of historical fact may be deemed forward-looking statements. Without limiting the foregoing, the words “believes,” “anticipates,” “plans,” “expects,” “intends,” “appears,” “estimates,” “projects,” “will,” “would,” “could,” “should,” “targets,” and similar expressions are also intended to identify forward-looking statements. The forward-looking statements in this release involve a number of risks and uncertainties. Such factors and others are discussed in the section entitled “Risk Factors” of the Company’s most recent Annual Report on Form 10-K and subsequent quarterly reports on Form 10-Q as filed with the Securities and Exchange Commission, which “Risk Factors” discussion is incorporated by reference in this press release. The Company specifically disclaims any obligation to update these forward-looking statements in the future. These forward-looking statements should not be relied upon as representing the Company’s estimates or views as of any date subsequent to the date of this press release.